Showing 281-300 of 639 for: Cochrane Systematic Reviews > Cardiovascular 
- Home‐based versus centre‐based cardiac rehabilitation
Cochrane Systematic Reviews, 30-Jun-2017
Cardiovascular disease is the most common cause of death globally. Traditionally, centre-based cardiac rehabilitation programmes are offered to individuals after cardiac events to aid recovery and prevent further cardiac illness. Home-based cardiac rehabi
- Homocysteine lowering interventions for peripheral arterial disease and bypass grafts
Cochrane Systematic Reviews, 23-Jul-2013
Elevated plasma levels of the amino acid homocysteine (hyperhomocysteinaemia) are associated with narrowing or blocking of the arteries (atherosclerosis). Treatment to lower homocysteine levels has been shown to be both effective and cheap in healthy volu
- Homocysteine‐lowering interventions for preventing cardiovascular events
Cochrane Systematic Reviews, 17-Aug-2017
Cardiovascular disease, which includes coronary artery disease, stroke and peripheral vascular disease, is a leading cause of death worldwide. Homocysteine is an amino acid with biological functions in methionine metabolism. A postulated risk factor for c
- Hormone therapy for preventing cardiovascular disease in post‐menopausal women
Cochrane Systematic Reviews, 10-Mar-2015
Evidence from systematic reviews of observational studies suggests that hormone therapy may have beneficial effects in reducing the incidence of cardiovascular disease events in post-menopausal women, however the results of randomised controlled trials (R
- Horse chestnut seed extract for chronic venous insufficiency
Cochrane Systematic Reviews, 14-Nov-2012
Conservative therapy of chronic venous insufficiency (CVI) consists largely of compression treatment. However, this often causes discomfort and has been associated with poor compliance. Therefore, oral drug treatment is an attractive option. This is an up
- Human albumin solution for resuscitation and volume expansion in critically ill patients
Cochrane Systematic Reviews, 9-Nov-2011
Human albumin solutions are used for a range of medical and surgical problems. Licensed indications are the emergency treatment of shock and other conditions where restoration of blood volume is urgent, such as in burns and hypoproteinaemia. Human albumin
- Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases
Cochrane Systematic Reviews, 14-Mar-2012
Mortality from upper gastrointestinal bleeding in patients with liver disease is high. Recombinant human activated factor VII (rHuFVIIa) has been suggested for patients with liver disease and upper gastrointestinal bleeding.
- Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
Cochrane Systematic Reviews, 12-Dec-2012
Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been introduced to reduce the high risk of death associated with severe sepsis or septic shock. This systematic review is an update of a Cochrane review ori
- Hydralazine for essential hypertension
Cochrane Systematic Reviews, 4-Oct-2011
Hypertension is associated with an increased risk of stroke, myocardial infarction and congestive heart failure. Hydralazine is a direct-acting vasodilator which has been used for the treatment of hypertension since the 1950's. Although it has largely bee
- Hydration for treatment of preterm labour
Cochrane Systematic Reviews, 19-Dec-2013
Hydration has been proposed as a treatment for women with preterm labour. Theoretically, hydration may reduce uterine contractility by increasing uterine blood flow and by decreasing pituitary secretion of antidiuretic hormone and oxytocin.
- Hydrogel dressings for healing diabetic foot ulcers
Cochrane Systematic Reviews, 12-Jul-2013
Foot ulcers in people with diabetes are a prevalent and serious global health issue. Dressings form a key part of ulcer treatment, with clinicians and patients having many different types to choose from including hydrogel dressings. A clear and current ov
- Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa
Cochrane Systematic Reviews, 31-May-2013
Malignant, or necrotising, otitis externa is a potentially fatal infection of the external ear canal and surrounding soft tissue and bone. It may be complicated by involvement of cranial nerves, principally the facial nerves and the contents of the jugula
- Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus
Cochrane Systematic Reviews, 17-Oct-2012
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 1, 2005 and previously updated in 2007 and 2009.
- Hyperbaric oxygen therapy for acute coronary syndrome
Cochrane Systematic Reviews, 23-Jul-2015
Acute coronary syndrome (ACS), includes acute myocardial infarction and unstable angina, is common and may prove fatal. Hyperbaric oxygen therapy (HBOT) will improve oxygen supply to the threatened heart and may reduce the volume of heart muscle that peri
- Hyperbaric oxygen therapy for acute ischaemic stroke
Cochrane Systematic Reviews, 12-Nov-2014
Most cases of stroke are caused by impairment of blood flow to the brain (ischaemia), which results in a reduction in available oxygen and subsequent cell death. It has been postulated that hyperbaric oxygen therapy (HBOT) may reduce the volume of brain t
- Hyperbaric oxygen therapy for chronic wounds
Cochrane Systematic Reviews, 24-Jun-2015
Chronic wounds are common and present a health problem with significant effect on quality of life. Various pathologies may cause tissue breakdown, including poor blood supply resulting in inadequate oxygenation of the wound bed. Hyperbaric oxygen therapy
- Hyperbaric oxygen therapy for multiple sclerosis
Cochrane Systematic Reviews, 26-Jan-2004
Multiple Sclerosis (MS) is a chronic, recurrent and progressive illness with no cure. On the basis of speculative pathophysiology, it has been suggested that Hyperbaric Oxygen Therapy (HBOT) may slow or reverse the progress of the disease.
- Hyperbaric oxygen therapy for promoting fracture healing and treating fracture non-union
Cochrane Systematic Reviews, 2-Oct-2012
Hyperbaric oxygen therapy (HBOT) consists of intermittently administering 100% oxygen at pressures greater than one atmosphere absolute (ATA) in a pressure vessel. This technology has been used to treat a variety of diseases and has been described as help
- Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury
Cochrane Systematic Reviews, 19-Nov-2012
Traumatic brain injury is a common health problem with significant effect on quality of life. Each year in the USA approximately 0.56% of the population suffer a head injury, with a case fatality rate of about 40% for severe injuries. These account for a
- Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients
Cochrane Systematic Reviews, 19-Jul-2004
Hypertonic solutions are considered to have a greater ability to expand blood volume and thus elevate blood pressure and can be administered as a small volume infusion over a short time period. On the other hand, the use of hypertonic solutions for volume
